(Q37291912)

19 August 2017

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone (English)

1 reference

19 August 2017

3

Jones RN

1 reference

19 August 2017

2

Barry AL

1 reference

19 August 2017

1

Thornsberry C

1 reference

19 August 2017

C. N. Baker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

30 August 2023

R. E. Badal

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

30 August 2023

language of work or name

English

0 references

publication date

1 May 1982

1 reference

full work available at URL

19 August 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6212595/pdf/?tool=EBI

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6212595/?tool=EBI

30 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

http://intl-jcm.asm.org/cgi/content/abstract/15/5/769

30 August 2023

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

https://europepmc.org/articles/PMC272188

30 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

https://europepmc.org/articles/PMC272188?pdf=render

30 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212595

https://journals.asm.org/doi/pdf/10.1128/jcm.15.5.769-776.1982

30 August 2023

1 reference

10.1128/JCM.15.5.769-776.1982

Crossref

DOI

https://api.crossref.org/works/10.1128/JCM.15.5.769-776.1982

Journal of Clinical Microbiology

30 August 2023

published in

1 reference

19 August 2017

15

1 reference

19 August 2017

5

1 reference

19 August 2017

769-776

1 reference

Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine Cephalosporin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=272188

Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates

26 June 2018

1 reference

12 December 2020

Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics

1 reference

12 December 2020

Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test

1 reference

12 December 2020

Single-dose pharmacokinetics of cefoperazone following intravenous administration

1 reference

12 December 2020

Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats

1 reference

12 December 2020

Cefoperazone: absorption, excretion, distribution, and metabolism

1 reference

12 December 2020

Comparative pharmacokinetics of cefoperazone and cefotaxime

1 reference

12 December 2020

10.1128/JCM.15.5.769-776.1982

Identifiers

DOI

0 references

1 reference

19 August 2017

1 reference